Atuss Ds Tannate Suspension
Product Images NDC 59702-800

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Atuss Ds Tannate Suspension (NDC 59702-800). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atley Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chlorpheniramine Maleate (Atley Pharma Atuss Ds Chlorpheniramine Maleate)

FDA Label Image

Dextromethorphan Hydrobromide (Atley Pharma Atuss Ds Dextromethorphan Hydrobromide)

FDA Label Image

Pseudoephedrine Hydrochloride (Atley Pharma Atuss Ds Pseudoephedrine Hydrochloride)

FDA Label Image

Atuss Ds Package Label (Atley Pharma Atuss Ds Label)

Atuss Ds Package Label (Atley Pharma Atuss Ds Label)
This appears to be a medication label, providing dosage instructions and specific information for pharmacists. The medication is a tannate suspension, and the recommended dosage is one to two teaspoonsful every 12 hours. The medication contains dextromethorphan, Pseudoephedrine HCI, and Chlorpheniramine maleate. The medication should be stored at controlled room temperature (68°-77°F) and should be shaken well before use. The label also includes the medication's name, strength, and manufacturer information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.